PET/MR Imaging of the Pancreas

Nadine Mallak; Thomas A Hope; Alexander R Guimaraes

doi:10.1016/j.mric.2018.03.003

PET/MR Imaging of the Pancreas

Magn Reson Imaging Clin N Am. 2018 Aug;26(3):345-362. doi: 10.1016/j.mric.2018.03.003.

Authors

Nadine Mallak¹, Thomas A Hope², Alexander R Guimaraes³

Affiliations

¹ Department of Diagnostic Radiology, Oregon Health & Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.
² Department of Radiology and Biomedical Imaging, University of California, San Francisco, 505 Parnassus Avenue, M391, San Francisco, CA 94158, USA.
³ Department of Diagnostic Radiology, Oregon Health & Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. Electronic address: [email protected].

PMID: 30376974
DOI: 10.1016/j.mric.2018.03.003

Abstract

PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.

Keywords: DOTATATE; Neuroendocrine tumor; PET/MR imaging; Pancreas.

Publication types

Review

MeSH terms

Humans
Magnetic Resonance Imaging / methods*
Multimodal Imaging / methods*
Pancreas / diagnostic imaging
Pancreatic Diseases / diagnostic imaging*
Positron-Emission Tomography / methods*